Dab2 is a key regulator of endocytosis and post-endocytic trafficking of the cystic fibrosis transmembrane conductance regulator

被引:35
|
作者
Fu, Lianwu [1 ,2 ]
Rab, Andras [1 ]
Tang, Li Ping [2 ,3 ]
Rowe, Steven M. [2 ,3 ]
Bebok, Zsuzsa [1 ,2 ]
Collawn, James F. [1 ,2 ]
机构
[1] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA
[2] Univ Alabama, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Med, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
adaptor protein 2 (AP-2); casitas B-lineage lymphoma (c-Cbl); C-terminus of the Hsc (heat-shock cognate) 70-interacting protein (CHIP); cystic fibrosis transmembrane conductance regulator (CFTR); Disabled-2 (Dab2); endocytosis; ADAPTER PROTEIN DAB2; MYOSIN-VI; COATED PITS; CLATHRIN ADAPTERS; EPITHELIAL-CELLS; DELTA-F508; CFTR; PLASMA-MEMBRANE; TERMINAL TAIL; WILD-TYPE; RECEPTOR;
D O I
10.1042/BJ20111566
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CFTR (cystic fibrosis transmembrane conductance regulator) is expressed in the apical membrane of epithelial cells. Cell-surface CFTR levels are regulated by endocytosis and recycling. A number of adaptor proteins including AP-2 (mu 2 subunit) and Dab2 (Disabled-2) have been proposed to modulate CFTR internalization. In the present study we have used siRNA (small interfering RNA)-mediated silencing of these adaptors to test their roles in the regulation of CFTR cell-surface trafficking and stability in human airway epithelial cells. The results indicate that mu 2 and Dab2 performed partially overlapping, but divergent, functions. While mu 2 depletion dramatically decreased CFTR endocytosis with little effect on the half-life of the CFTR protein, Dab2 depletion increased the CFTR half-life similar to 3-fold, in addition to inhibiting CFTR endocytosis. Furthermore, Dab2 depletion inhibited CFTR trafficking from the sorting endosome to the recycling compartment, as well as delivery of CFTR to the late endosome, thus providing a mechanistic explanation for increased CFTR expression and half-life. To test whether two E3 ligases were required for the endocytosis and/or down-regulation of surface CFTR, we siRNA-depleted CHIP [C-terminus of the Hsc (heat-shock cognate) 70-interacting protein] and c-Cbl (casitas B-lineage lymphoma). We demonstrate that CHIP and c-Cbl depletion have no effect on CFTR endocytosis, but c-Cbl depletion modestly enhanced the half-life of CFTR. The results of the present study define a significant role for Dab2 both in the endocytosis and post-endocytic fate of CFTR.
引用
收藏
页码:633 / 643
页数:11
相关论文
共 50 条
  • [41] The cystic fibrosis transmembrane conductance regulator: state of the art
    Davies, J. C.
    BREATHE, 2008, 5 (02) : 163 - 167
  • [42] Atomic Structure of the Cystic Fibrosis Transmembrane Conductance Regulator
    Zhang, Zhe
    Chen, Jue
    CELL, 2016, 167 (06) : 1586 - +
  • [43] TARGETED ACTIVATION OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
    Villamizar, O.
    Waters, S.
    Scott, T.
    Saayman, S.
    Grepo, N.
    Urak, R.
    Davis, A.
    Morris, K.
    Jaffe, A.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S183 - S184
  • [44] Endocytic Adaptor Protein DAB2 is a Novel Atheroprotective Regulator in Atherosclerosis
    Cui, Kui
    Dong, Yunzhou
    Wang, Beibei
    Li, Kathryn
    Shyy, John
    Chen, Hong
    CIRCULATION, 2023, 148
  • [45] Chloride channel and chloride conductance regulator domains of CFTR, the cystic fibrosis transmembrane conductance regulator
    Schwiebert, EM
    Morales, MM
    Devidas, S
    Egan, ME
    Guggino, WB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) : 2674 - 2679
  • [46] The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
    Sergeev, Valentine
    Chou, Frank Y.
    Lam, Grace Y.
    Hamilton, Christopher Michael
    Wilcox, Pearce G.
    Quon, Bradley S.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (02) : 147 - 154
  • [47] Efficient endocytosis of the cystic fibrosis transmembrane conductance regulator requires a tyrosine-based signal
    Prince, LS
    Peter, K
    Hatton, SR
    Zaliauskiene, L
    Cotlin, LF
    Clancy, JP
    Marchase, RB
    Collawn, JF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (06) : 3602 - 3609
  • [48] Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis
    Burgener, Elizabeth B.
    Moss, Richard B.
    CURRENT OPINION IN PEDIATRICS, 2018, 30 (03) : 372 - 377
  • [49] Tritherapy with cystic fibrosis transmembrane conductance regulator protein modulators in cystic fibrosis
    Colodro, Oscar Fielbaum
    Grell, Alberto Vidal
    Yarur, Alejandra Mendez
    Clerc, Camila Sobarzo
    ANDES PEDIATRICA, 2022, 93 (06): : 898 - 905
  • [50] Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein
    Riordan, JR
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (06) : 1499 - 1504